Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S1W-10622 · Session 1

What new guidance it has given to health boards regarding the prescribing of Beta Interferon.

Answered Asked by Margo MacDonald SNP Lodged 25 Oct 2000

The question

To ask the Scottish Executive what new guidance it has given to health boards regarding the prescribing of Beta Interferon.

The answer

Answered by Susan Deacon on 8 Nov 2000 · 14 days after it was lodged, on time

No new guidance has been issued. In 1995, guidance about new drugs for multiple sclerosis and clinical advice from the Scottish Medical Advisory Committee was issued to all health boards and this guidance continues to apply.The Health Technology Board for Scotland is at present carrying out an assessment of Beta Interferon and Copaxone in the treatment of multiple sclerosis.

In the Official Report

No contribution in the Official Report cites S1W-10622 by reference.